Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling
Summary: Alternative splicing is well understood to enhance proteome diversity as cells respond to stimuli. However, mechanistic understanding for how the spliceosome processes precursor messenger RNA (mRNA) transcripts to achieve template diversification is incomplete. We use recently developed enz...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124720300796 |
id |
doaj-c0c2219a2c9a4202a4e9067663eea1ff |
---|---|
record_format |
Article |
spelling |
doaj-c0c2219a2c9a4202a4e9067663eea1ff2020-11-24T22:00:00ZengElsevierCell Reports2211-12472020-02-0130619351950.e8Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon SignalingPatrick J. Metz0Keith A. Ching1Tao Xie2Paulina Delgado Cuenca3Sherry Niessen4John H. Tatlock5Kristen Jensen-Pergakes6Brion W. Murray7Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA; Corresponding authorComputational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USAComputational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USATumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USATumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USAWorldwide Medicinal Chemistry, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USATumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USATumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USASummary: Alternative splicing is well understood to enhance proteome diversity as cells respond to stimuli. However, mechanistic understanding for how the spliceosome processes precursor messenger RNA (mRNA) transcripts to achieve template diversification is incomplete. We use recently developed enzymatic inhibitors of protein arginine methyltransferase 5 (PRMT5) and human naive T lymphocyte activation as a model system to uncover a precise set of mRNA transcripts that require symmetric arginine dimethylation. This methylation-dependent splicing selectivity is associated with a limited set of signaling pathways that are affected when PRMT5 is inhibited. Specifically, we identify a conserved role for symmetric arginine dimethylation in the induction of antiviral type I and type III interferon signaling following T cell receptor and pattern recognition receptor stimulation in human T lymphocytes and undifferentiated human THP-1 monocytes. Altogether, these findings reveal a mechanism by which cells may be enabled to precisely modulate transcript heterogeneity to orchestrate specific functional outcomes. : Metz et al. employ an optimized chemical toolkit to uncover the unexpected precision with which symmetric arginine dimethylation regulates mRNA splicing. They identify an associated requirement for PRMT5-dependent signaling in the production of antimicrobial type I and type III interferons that is conserved across innate and adaptive immune cells. Keywords: PRMT5, PRMT5 chemical toolkit, precursor mRNA splicing, type I and type III interferon signaling, human innate and adaptive immune systemhttp://www.sciencedirect.com/science/article/pii/S2211124720300796 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Patrick J. Metz Keith A. Ching Tao Xie Paulina Delgado Cuenca Sherry Niessen John H. Tatlock Kristen Jensen-Pergakes Brion W. Murray |
spellingShingle |
Patrick J. Metz Keith A. Ching Tao Xie Paulina Delgado Cuenca Sherry Niessen John H. Tatlock Kristen Jensen-Pergakes Brion W. Murray Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling Cell Reports |
author_facet |
Patrick J. Metz Keith A. Ching Tao Xie Paulina Delgado Cuenca Sherry Niessen John H. Tatlock Kristen Jensen-Pergakes Brion W. Murray |
author_sort |
Patrick J. Metz |
title |
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling |
title_short |
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling |
title_full |
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling |
title_fullStr |
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling |
title_full_unstemmed |
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling |
title_sort |
symmetric arginine dimethylation is selectively required for mrna splicing and the initiation of type i and type iii interferon signaling |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2020-02-01 |
description |
Summary: Alternative splicing is well understood to enhance proteome diversity as cells respond to stimuli. However, mechanistic understanding for how the spliceosome processes precursor messenger RNA (mRNA) transcripts to achieve template diversification is incomplete. We use recently developed enzymatic inhibitors of protein arginine methyltransferase 5 (PRMT5) and human naive T lymphocyte activation as a model system to uncover a precise set of mRNA transcripts that require symmetric arginine dimethylation. This methylation-dependent splicing selectivity is associated with a limited set of signaling pathways that are affected when PRMT5 is inhibited. Specifically, we identify a conserved role for symmetric arginine dimethylation in the induction of antiviral type I and type III interferon signaling following T cell receptor and pattern recognition receptor stimulation in human T lymphocytes and undifferentiated human THP-1 monocytes. Altogether, these findings reveal a mechanism by which cells may be enabled to precisely modulate transcript heterogeneity to orchestrate specific functional outcomes. : Metz et al. employ an optimized chemical toolkit to uncover the unexpected precision with which symmetric arginine dimethylation regulates mRNA splicing. They identify an associated requirement for PRMT5-dependent signaling in the production of antimicrobial type I and type III interferons that is conserved across innate and adaptive immune cells. Keywords: PRMT5, PRMT5 chemical toolkit, precursor mRNA splicing, type I and type III interferon signaling, human innate and adaptive immune system |
url |
http://www.sciencedirect.com/science/article/pii/S2211124720300796 |
work_keys_str_mv |
AT patrickjmetz symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT keithaching symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT taoxie symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT paulinadelgadocuenca symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT sherryniessen symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT johnhtatlock symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT kristenjensenpergakes symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling AT brionwmurray symmetricargininedimethylationisselectivelyrequiredformrnasplicingandtheinitiationoftypeiandtypeiiiinterferonsignaling |
_version_ |
1725846086236504064 |